2005
DOI: 10.1016/j.humpath.2005.05.005
|View full text |Cite
|
Sign up to set email alerts
|

Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
66
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 68 publications
(74 citation statements)
references
References 42 publications
7
66
1
Order By: Relevance
“…The main results are that fascin is upregulated in most colonic carcinomas, correlating with a higher tumour grade, right tumour location and tumour stage, and that fascin immunoreactivity is an independent predictor of reduced OS and DFS in patients with advanced tumour stage. A growing body of literature reports that fascin is expressed in many types of transformed epithelial cell lines and in several solid neoplasms (Grothey et al, 2000;Hu et al, 2000;Goncharuk et al, 2002;Jawhari et al, 2003;Pelosi et al, 2003a, b;Hashimoto et al, 2004Hashimoto et al, , 2005aHashimoto et al, , 2006Tong et al, 2005;Xie et al, 2005;Yoder et al, 2005;Choi et al, 2006;Zhang et al, 2006) where it correlates with tumour stage (Hashimoto et al, 2004(Hashimoto et al, , 2005aYoder et al, 2005;Choi et al, 2006) and grade (Pelosi et al, 2003b;Hashimoto et al, 2004;Yoder et al, 2005), pT class (Hashimoto et al, 2004(Hashimoto et al, , 2005a, lymph node involvement (Hashimoto et al, 2004(Hashimoto et al, , 2005aChoi et al, 2006;Zhang et al, 2006), recurrence (Hashimoto et al, 2004), and both OS (Hashimoto et al, 2004(Hashimoto et al, , 2005a(Hashimoto et al, , 2006Yoder et al, 2005) and DFS (Pelosi et al, 2003b;Yoder et al, 2005). The close association we found between fascin immunoreactivity and tumour stage, tumour grade, the number and type of lymph node involvement, and distant metastasis indicates the major role of fascin in the progression of colonic adenocarcinoma.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The main results are that fascin is upregulated in most colonic carcinomas, correlating with a higher tumour grade, right tumour location and tumour stage, and that fascin immunoreactivity is an independent predictor of reduced OS and DFS in patients with advanced tumour stage. A growing body of literature reports that fascin is expressed in many types of transformed epithelial cell lines and in several solid neoplasms (Grothey et al, 2000;Hu et al, 2000;Goncharuk et al, 2002;Jawhari et al, 2003;Pelosi et al, 2003a, b;Hashimoto et al, 2004Hashimoto et al, , 2005aHashimoto et al, , 2006Tong et al, 2005;Xie et al, 2005;Yoder et al, 2005;Choi et al, 2006;Zhang et al, 2006) where it correlates with tumour stage (Hashimoto et al, 2004(Hashimoto et al, , 2005aYoder et al, 2005;Choi et al, 2006) and grade (Pelosi et al, 2003b;Hashimoto et al, 2004;Yoder et al, 2005), pT class (Hashimoto et al, 2004(Hashimoto et al, , 2005a, lymph node involvement (Hashimoto et al, 2004(Hashimoto et al, , 2005aChoi et al, 2006;Zhang et al, 2006), recurrence (Hashimoto et al, 2004), and both OS (Hashimoto et al, 2004(Hashimoto et al, , 2005a(Hashimoto et al, , 2006Yoder et al, 2005) and DFS (Pelosi et al, 2003b;Yoder et al, 2005). The close association we found between fascin immunoreactivity and tumour stage, tumour grade, the number and type of lymph node involvement, and distant metastasis indicates the major role of fascin in the progression of colonic adenocarcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the protein promotes cell locomotion (Yamashiro et al, 1998) and participates in the mechanical organisation of stress fibres (Adams, 1997). A definite overexpression of fascin has been reported in carcinomas of different organs, including oesophagus (Hashimoto et al, 2005a;Xie et al, 2005;Zhang et al, 2006), stomach (Hashimoto et al, 2004), colon (Jawhari et al, 2003;Hashimoto et al, 2006), pancreas (Maitra et al, 2002), breast (Grothey et al, 2000;Yoder et al, 2005), skin (Goncharuk et al, 2002), lung (Pelosi et al, 2003a, b;Choi et al, 2006), urinary bladder (Tong et al, 2005), and ovary (Hu et al, 2000) and the protein has been recently proposed as a novel biomarker for aggressive tumour behaviour (Hashimoto et al, 2005b(Hashimoto et al, , 2006Zhang et al, 2006). In colonic adenocarcinoma cell lines, fascin overexpression correlates with an increase in the formation of dynamic cell protrusions, proliferation, and invasiveness (Jawhari et al, 2003).…”
mentioning
confidence: 99%
“…It is required for the formation of actin-based cell-surface protrusions that are essential for cellular migration and cellmatrix adhesion. [15][16][17] In normal epithelial cells, fascin expression is usually absent or very low, but it is significantly upregulated in transformed epithelial cells and several types of human carcinoma such as lung, 18,19 breast, [20][21][22][23] esophagus, 24,25 stomach, 26 colon, 27 pancreas, [28][29][30][31] biliary tract and ampulla, 31,32 ovary, 33 urinary bladder, 34 and skin. 35 Among the above neoplasms, fascin upregulation is most frequently observed in pancreatic infiltrating adenocarcinoma.…”
mentioning
confidence: 99%
“…Fascin over-expression is associated with increased invasiveness of carcinomas in the urinary bladder [21,30], where benign proliferative lesions such as nephrogenic adenoma, IP, and exophytic papilloma were negative for fascin [21]. Its over-expression is seen more often in dysplastic epithelium in sinonasal IP, and may be organ specific.…”
Section: Discussionmentioning
confidence: 99%
“…Immunohistochemisty staining was performed according to previously published methods, with minor modification [21,22]. Immunohistochemical staining was performed on 4 lm thick paraffin embedded tissue section using the Streptavidin peroxidase conjugated method with human fascin 1 monoclonal antibody, clone 55 k-2 (1:100 dilution; Neomarkers, Fremont, CA).…”
Section: Methodsmentioning
confidence: 99%